,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-02-22 03:03:00,Veeva Systems Inc. (NYSE: VEEV) had a great 2017.,0.8865866661071777,0.014920547604560852,0.09849273413419724,positive,0.8716661334037781
1,2018-02-22 03:03:00,The stock soared nearly 36%.,0.9152487516403198,0.02203119918704033,0.06272011250257492,positive,0.8932175636291504
2,2018-02-22 03:03:00,Veeva's cloud-based applications for the life sciences market continued to enjoy strong demand.,0.9428901672363281,0.014795645140111446,0.04231429100036621,positive,0.9280945062637329
3,2018-02-22 03:03:00,"However, all of its gains were made in the first five months of the year.",0.9165986180305481,0.02240549772977829,0.06099577620625496,positive,0.8941931128501892
4,2018-02-22 03:03:00,"From June through the end of the year, the stock fell 15%.",0.01756795309484005,0.9722990393638611,0.010133046656847,negative,-0.9547311067581177
5,2018-02-22 03:03:00,"So far in 2018, though, Veeva is bouncing back nicely.",0.9166611433029175,0.025739368051290512,0.057599522173404694,positive,0.8909217715263367
6,2018-02-22 03:03:00,"Double-digit percentage swings are par for the course with a high-growth, high-valuation stock like Veeva Systems.",0.28771963715553284,0.03772358223795891,0.6745567917823792,neutral,0.24999605119228363
7,2018-02-22 03:03:00,It's more important for investors to look at the company's business model and opportunities for future growth.,0.12000022083520889,0.005368351936340332,0.8746314644813538,neutral,0.11463186889886856
8,2018-02-22 03:03:00,"With a long-term view in mind, is Veeva Systems a buy?",0.10479152947664261,0.0206743236631155,0.8745341897010803,neutral,0.08411720395088196
9,2018-02-22 03:03:00,"In my view, the single most compelling reason to buy Veeva stock is the company's moat .",0.09252368658781052,0.006460875738412142,0.9010154604911804,neutral,0.08606281131505966
10,2018-02-22 03:03:00,"Just like medieval castles had a moat of water that served as a barrier to protect against enemies, Veeva's products protect it from rivals.",0.13644181191921234,0.014889228157699108,0.8486689329147339,neutral,0.12155258655548096
11,2018-02-22 03:03:00,How?,0.09705228358507156,0.03652043268084526,0.8664273023605347,neutral,0.0605318509042263
12,2018-02-22 03:03:00,Three words: high switching costs.,0.05171189084649086,0.0223727747797966,0.9259153604507446,neutral,0.02933911606669426
13,2018-02-22 03:03:00,Veeva's core products includes its customer relationship management (CRM) system and its Vault suite of applications that help biopharmaceutical companies manage the drug development process.,0.06478136032819748,0.0044011869467794895,0.9308174848556519,neutral,0.06038017198443413
14,2018-02-22 03:03:00,"Customers that use Veeva's applications must load all of their data, including customers, clinical trial data, and much more, into the systems.",0.01580026000738144,0.008561981841921806,0.9756377935409546,neutral,0.007238278165459633
15,2018-02-22 03:03:00,"To leave Veeva for a rival system, a customer would have to convert all of that data to the new system -- a time-consuming and costly process.",0.040358297526836395,0.5105384588241577,0.4491032660007477,negative,-0.4701801538467407
16,2018-02-22 03:03:00,"In addition, the customer would need to train all of its employees on the new system, requiring even more time and cost.",0.21593070030212402,0.481967955827713,0.30210140347480774,negative,-0.266037255525589
17,2018-02-22 03:03:00,These switching costs mean that customers tend to stay on Veeva's products.,0.029827089980244637,0.6589977145195007,0.3111751973628998,negative,-0.6291705965995789
18,2018-02-22 03:03:00,"At the same time, though, Veeva continues to roll out new products that meet additional customer needs.",0.6847679018974304,0.009740907698869705,0.30549120903015137,positive,0.6750270128250122
19,2018-02-22 03:03:00,"For example, in 2017 the company launched Vault EDC (electronic data capture) and Vault eSource.",0.11674084514379501,0.004874641075730324,0.878384530544281,neutral,0.11186620593070984
20,2018-02-22 03:03:00,"The former product enables clinical trial sites, sponsors, and contract research organizations to easily and quickly access clinical data, while the latter product integrates electronic source data directly into Vault EDC.",0.09203898906707764,0.005312427878379822,0.9026486277580261,neutral,0.08672656118869781
21,2018-02-22 03:03:00,"As more customers adopt these and other new products, it becomes even harder for them to switch to a competing system.",0.0929933562874794,0.14530394971370697,0.7617027759552002,neutral,-0.05231059342622757
22,2018-02-22 03:03:00,New products also allow Veeva to expand its total addressable market.,0.9376185536384583,0.014223591424524784,0.048157889395952225,positive,0.9233949780464172
23,2018-02-22 03:03:00,The company is even moving into entirely new markets outside of the life sciences industry.,0.4697321057319641,0.009365925565361977,0.5209019184112549,neutral,0.4603661894798279
24,2018-02-22 03:03:00,"Last year, Veeva landed a large consumer packaged goods customer.",0.7669880986213684,0.01307437103241682,0.21993756294250488,positive,0.7539137005805969
25,2018-02-22 03:03:00,"Although its expansion into new markets might move relatively slowly at first, this represents a tremendous growth opportunity for the company.",0.9215977787971497,0.013517237268388271,0.06488499790430069,positive,0.908080518245697
26,2018-02-22 03:03:00,"With its strong moat and solid growth prospects, why wouldn't investors want to buy Veeva?",0.5497078895568848,0.01594911329448223,0.4343430697917938,positive,0.5337587594985962
27,2018-02-22 03:03:00,Probably the top reason would be that they think the stock is expensive and that much of the growth is already baked into the share price.,0.03338920697569847,0.11485137790441513,0.8517594337463379,neutral,-0.08146217465400696
28,2018-02-22 03:03:00,Veeva stock currently trades at 71 times trailing-12-month earnings and 60 times expected earnings.,0.05523483082652092,0.007614775560796261,0.9371503591537476,neutral,0.047620054334402084
29,2018-02-22 03:03:00,Those are nosebleed valuation levels.,0.030576249584555626,0.029651228338479996,0.9397725462913513,neutral,0.0009250212460756302
30,2018-02-22 03:03:00,"But Veeva has expanded rapidly and more growth is expected, so is the stock cheap factoring in growth prospects?",0.6687889695167542,0.01921597681939602,0.3119949996471405,positive,0.6495729684829712
31,2018-02-22 03:03:00,"Actually, no.",0.0866352841258049,0.08886206895112991,0.8245026469230652,neutral,-0.002226784825325012
32,2018-02-22 03:03:00,The stock's price-to-earnings-to-growth (PEG) ratio of 2.96 is also really high.,0.6284626126289368,0.01713588833808899,0.35440149903297424,positive,0.6113266944885254
33,2018-02-22 03:03:00,Then there's the Wall Street projections that Veeva's growth rate will slow.,0.021210430189967155,0.9134349822998047,0.06535454839468002,negative,-0.8922245502471924
34,2018-02-22 03:03:00,"Over the last five years, Veeva grew earnings by more than 42% per year on average.",0.9483174085617065,0.015451209619641304,0.03623143583536148,positive,0.9328662157058716
35,2018-02-22 03:03:00,"However, analysts think that the company's earnings growth will slow to roughly half that amount over the next five years.",0.01799672096967697,0.9516772627830505,0.03032596968114376,negative,-0.933680534362793
36,2018-02-22 03:03:00,The reality is Veeva isn't the hot growth story that it once was.,0.025178225710988045,0.02881336584687233,0.9460084438323975,neutral,-0.003635140135884285
37,2018-02-22 03:03:00,"It's got over 600 customers, including many of the largest biopharmaceutical companies in the world.",0.2825642228126526,0.007143659982830286,0.7102921009063721,neutral,0.27542057633399963
38,2018-02-22 03:03:00,Investors looking for sizzling growth could potentially find other stocks that are earlier in their life cycle than Veeva is and that aren't as expensive.,0.049817267805337906,0.030271047726273537,0.9199116230010986,neutral,0.01954622007906437
39,2018-02-22 03:03:00,"Several years ago, I would have looked at Veeva's earnings multiples and concluded the stock was too pricey to buy.",0.0529104582965374,0.3570495843887329,0.5900399088859558,neutral,-0.3041391372680664
40,2018-02-22 03:03:00,I would have put faith in Wall Street's projections of slowing growth and stayed clear of the stock altogether.,0.1370166391134262,0.10193027555942535,0.7610530853271484,neutral,0.035086363554000854
41,2018-02-22 03:03:00,"Now, however, my opinions are formed more by a company's business model and moat than they are by current numbers and analysts' best guesses about the future.",0.03596825897693634,0.007218548096716404,0.9568132162094116,neutral,0.02874971181154251
42,2018-02-22 03:03:00,"In my view, Veeva has about as solid of a business model and moat as they come.",0.43278956413269043,0.009571448899805546,0.5576390027999878,neutral,0.42321810126304626
43,2018-02-22 03:03:00,The company has great products that meet customer needs.,0.6421241164207458,0.010563126765191555,0.3473128080368042,positive,0.6315609812736511
44,2018-02-22 03:03:00,It continues to innovate by rolling out new products.,0.8201644420623779,0.010958210565149784,0.16887742280960083,positive,0.8092062473297119
45,2018-02-22 03:03:00,Veeva isn't limiting itself to just one industry.,0.019886616617441177,0.007311591412872076,0.9728018045425415,neutral,0.012575024738907814
46,2018-02-22 03:03:00,"Sure, the stock is expensive.",0.044064078480005264,0.018282093107700348,0.9376537799835205,neutral,0.025781985372304916
47,2018-02-22 03:03:00,"But just as you would expect to pay more for a room at a five-star resort than you would at a motel by the interstate, you pay more for quality stocks.",0.20718182623386383,0.0161724966019392,0.7766456604003906,neutral,0.19100932776927948
48,2018-02-22 03:03:00,Veeva is a quality stock that I still think is a smart long-term pick.,0.7877196073532104,0.011980759911239147,0.20029962062835693,positive,0.7757388353347778
49,2018-02-22 03:03:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
50,2018-02-22 03:03:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
51,2018-02-22 03:03:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
52,2018-02-22 03:03:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
53,2018-02-22 03:03:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
54,2018-02-22 03:03:00,Keith Speights has no position in any of the stocks mentioned.,0.009128669276833534,0.045183293521404266,0.9456880688667297,neutral,-0.03605462610721588
55,2018-02-22 03:03:00,The Motley Fool owns shares of and recommends Veeva Systems.,0.034477271139621735,0.013045232743024826,0.9524774551391602,neutral,0.02143203839659691
56,2018-02-22 03:03:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
57,2018-02-22 03:03:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
